Erik Spaepen
Erik Spaepen publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Economics and Econometrics, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Diabetes Management and Education.
- World rank
- #3,285,809 of 7,710,434 ranked researchers
- Rank in United States
- #929,495 of 1,627,098
- Works
- 111
- Citations
- 1.4k
- Citations per work
- 12.3
What does Erik Spaepen research?
Erik Spaepen's work is mostly in Medicine (55%), Economics, Econometrics and Finance (5%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6154.6%
- Medicine6154.6%
- Everything else4136.8%
- Social Sciences54.8%
- Life Sciences43.8%
- 1Endocrinology, Diabetes and Metabolism39% of their works
- 2Surgery8% of their works
- 3Economics and Econometrics5% of their works
- 4Hematology4% of their works
- 5Genetics4% of their works
- 6Cardiology and Cardiovascular Medicine3% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes Management and Education
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Erythropoietin and Anemia Treatment
- Bariatric Surgery and Outcomes
- Diabetes and associated disorders
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe Erik Spaepen's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Type 1 Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Heart Failure.
- Cost-effectiveness Analysis
- Autoimmunity
- Bariatric Surgery
- Anemia
- Critical Care
- Depression
- Cardiovascular Outcomes
- Heart Failure
- Continuous Glucose Monitoring
- Cardiovascular Disease
- Insulin Therapy
- Glycemic Control
- Diabetes
- Type 1 Diabetes
- Hypoglycemia
- Type 2 Diabetes
- Glucose Control
- Self-Management
- Hyperglycemia
- Chronic Kidney Disease
- Obesity
- Genetics
- Quality of Life
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Glycemic Control1074 topics
- Insulin Therapy873 topics
- Diabetes723 topics
- Cardiovascular Disease542 topics
- Type 1 Diabetes512 topics
- Continuous Glucose Monitoring421 topic
- Hypoglycemia421 topic
- Heart Failure392 topics
- Type 2 Diabetes372 topics
- Cardiovascular Outcomes271 topic
- Glucose Control271 topic
- Depression201 topic
- Self-Management201 topic
- Critical Care181 topic
- Hyperglycemia181 topic
- Anemia121 topic
- Chronic Kidney Disease121 topic
- Bariatric Surgery101 topic
- Obesity101 topic
- Autoimmunity91 topic
- Genetics91 topic
- Cost-effectiveness Analysis71 topic
- Quality of Life71 topic
Where does Erik Spaepen work?
Erik Spaepen's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Erik Spaepen have?
OpenAlex counts 111 works and 1,370 citations for Erik Spaepen, an h-index of 13, ranking #3,285,809 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Erik Spaepen. Posts are plain text and can be reported.